CSC treated cells show enhanced viability during doxorubicin exposure.
- Yi An (300508)
- Alan Kiang (292168)
- Jay Patrick Lopez (300511)
- Selena Z. Kuo (300513)
- Michael Andrew Yu (292167)
- Eric L. Abhold (300514)
- Jocelyn S. Chen (300515)
- Jessica Wang-Rodriguez (28238)
- Weg M. Ongkeko (292173)
Publication date
February 2013
DOIAbstract
<p>MTS cell viability assays testing the viability of control vs. CSC-treated 10B and A549 cells in the presence of doxorubicin. Absorbance (Y-axis) values were normalized by dividing over the absorbance of the 0 µM doxorubicin samples. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047919#s3" target="_blank">Results</a> indicate that CSC has a protective effect against doxorubicin-induced cell death. Error bars represent SEM.</p
Add to ORKG